TGF-beta3: A potential biological therapy for enhancing chondrogenesis
about
Chondrogenic differentiation of marrow clots after microfracture with BMSC-derived ECM scaffold in vitroPreclinical and clinical data for the use of mesenchymal stem cells in articular cartilage tissue engineering.A Review of Arthroscopic Bone Marrow Stimulation Techniques of the Talus: The Good, the Bad, and the Causes for ConcernComparison of growth factor adsorbed scaffold and conventional scaffold with growth factor supplemented media for primary human articular chondrocyte 3D culture.Preclinical studies on mesenchymal stem cell-based therapy for growth plate cartilage injury repairThe effects of 1α, 25-dihydroxyvitamin D3 and transforming growth factor-β3 on bone development in an ex vivo organotypic culture system of embryonic chick femora.Biological responses to spider silk-antibiotic fusion protein.Exogenous Heparan Sulfate Enhances the TGF-β3-Induced Chondrogenesis in Human Mesenchymal Stem Cells by Activating TGF-β/Smad Signaling.Chondrogenesis of periodontal ligament stem cells by transforming growth factor-β3 and bone morphogenetic protein-6 in a normal healthy impacted third molar.Biologic Treatments for Sports Injuries II Think Tank-Current Concepts, Future Research, and Barriers to Advancement, Part 3: Articular CartilageThe Basic Science of Bone Marrow Aspirate Concentrate in Chondral Injuries.Bioactive factors in platelet-rich plasma obtained by apheresis.Cartilage tissue engineering: recent advances and perspectives from gene regulation/therapy.Chondrodysplasias and TGFβ signaling.Prolongation of T2 Stratification after Microfracture Does Not Indicate Normal Cartilage.Chondrogenic effect of precartilaginous stem cells following NLS-TAT cell penetrating peptide-assisted transfection of eukaryotic hTGFβ3.Prognostic significance of the containment and location of osteochondral lesions of the talus: independent adverse outcomes associated with uncontained lesions of the talar shoulder.Chondrogenic differentiation of mesenchymal stem cells in a hydrogel system based on an enzymatically crosslinked tyramine derivative of hyaluronan.Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis.The effect of temporal manipulation of transforming growth factor beta 3 and fibroblast growth factor 2 on the derivation of proliferative chondrocytes from mensenchymal stem cells-A study monitored by quantitative reverse transcription polymerase cChondrogenic effect of cell-based scaffold of self-assembling peptides/PLGA-PLL loading the hTGFβ3 plasmid DNA.Stem cells display a donor dependent response to escalating levels of growth factor release from extracellular matrix-derived scaffolds.Biochemical Stimulus-Based Strategies for Meniscus Tissue Engineering and Regeneration.Initial boost release of transforming growth factor-β3 and chondrogenesis by freeze-dried bioactive polymer scaffolds.Maintenance of human chondrogenic phenotype on a dendrimer-immobilized surface for an application of cell sheet engineering.Synergistic Effects of FGF-18 and TGF-β3 on the Chondrogenesis of Human Adipose-Derived Mesenchymal Stem Cells in the Pellet Culture.Successful Low-Cost Scaffold-Free Cartilage Tissue Engineering Using Human Cartilage Progenitor Cell Spheroids Formed by Micromolded Nonadhesive Hydrogel.Signalling by Transforming Growth Factor Beta Isoforms in Wound Healing and Tissue Regeneration.Type III Transforming Growth Factor- Receptor RNA Interference Enhances Transforming Growth Factor 3-Induced Chondrogenesis Signaling in Human Mesenchymal Stem Cells
P2860
Q34331292-849A2D92-53D6-4223-B383-E4401282F49CQ34333241-F00A4741-082F-4C93-9284-BD8DD607CFBDQ34977859-2EA1C11E-FFF5-4F85-8BEA-F50957BE1251Q34987887-8230FB05-BD34-43AB-91CF-B493984E7AFBQ35130994-7ADDB2AC-4997-4AD2-9972-23A06D26CA53Q35593203-5CEA8C72-FDA0-48D1-B7CD-8BBC21471B4FQ35910841-F1645DDA-EE2E-457C-875B-6FA1264C123DQ36405346-4C43C1FE-1AD0-4C92-8D9C-8DCD6E142B0BQ36785532-68FCB2E3-A572-4178-AE15-1CD8C640D75EQ36806142-E8788941-616F-4409-81EF-37FDAF4A803EQ37342796-1B869F0B-CF0C-4B30-8326-EB22762C5F43Q37513903-C3542588-4898-430E-9CCB-23900F63D67FQ38345989-11D13FDA-CF26-4E74-9132-A5BE189991D2Q38387152-8AA8DCF2-F490-419E-ACDB-7AF6667A180BQ42593813-977492FE-609A-46D4-85B2-375158B49053Q43409618-0EFA2458-D66C-4698-B365-32F46E1FF701Q43726722-CDABBFFE-2AFD-47B4-8718-66204E53EC0CQ46031104-B4698158-2C0E-43FB-B610-FB98262E2454Q47155242-5110C0D9-532B-4AA4-9AC6-30A69AB1C4D1Q47378372-565CEF1D-263E-4B7F-AF04-9D3361AB238EQ48068469-3739334D-19A8-4AFC-AD61-BD96D560FAABQ51252894-553339A0-11A8-4D89-8B7D-75CF50D3431BQ52629074-CE1E196C-5025-47B5-902A-AE82AD75EBB8Q52874228-19388AD8-DDBA-4CFD-AAD4-8C9BC8E688D2Q53434276-98868621-8858-4431-A6B0-9C266FE434C0Q54937537-67B63776-D608-4251-8AC7-A44E267802B1Q54997355-76E8B41D-82D1-4D2A-BB62-8813FF607328Q55281505-C74B5A36-7444-43AF-A78A-D11A8C48C61EQ57170317-08CA05BC-B205-4B8C-AEAE-981B9FB49BB1
P2860
TGF-beta3: A potential biological therapy for enhancing chondrogenesis
description
im Juni 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2009
@uk
name
TGF-beta3: A potential biological therapy for enhancing chondrogenesis
@en
TGF-beta3: A potential biological therapy for enhancing chondrogenesis
@nl
type
label
TGF-beta3: A potential biological therapy for enhancing chondrogenesis
@en
TGF-beta3: A potential biological therapy for enhancing chondrogenesis
@nl
prefLabel
TGF-beta3: A potential biological therapy for enhancing chondrogenesis
@en
TGF-beta3: A potential biological therapy for enhancing chondrogenesis
@nl
P2093
P1476
TGF-beta3: A potential biological therapy for enhancing chondrogenesis
@en
P2093
Athanasios Mantalaris
Eleftherios Tsiridis
Evgenios Tsiridis
Kaveh Shakib
Manolis Heliotis
Quen Oak Tang
Ugo Ripamonti
P304
P356
10.1517/14712590902936823
P407
P577
2009-06-01T00:00:00Z